NEKTAR THERAPEUTICS <NKTR.O>: JP MORGAN RESUMES COVERAGE WITH NEUTRAL RATING; TARGET PRICE $65

Reuters2026/08/21 04:32

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

HONEYWELL TECHNOLOGIES <HON.O>: BERNSTEIN CUTS TARGET PRICE TO $254 FROM $264

Reuters•2026/09/07 09:51

XRP targets $1.70 as Golden Cross formation nears after August rally

Cointurk•2026/09/07 09:45

Old Mutual to release half-year results update

Reuters•2026/09/07 09:34

XRP Rich List Update September 2026: How Much XRP Do You Need to Be in the Top 10%?

Coinpedia•2026/09/07 09:33